Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shafiq Cheema"'
Autor:
Naveen Siddique Sheikh, Mumtaz Touseef, Riddah Sultan, Kanwal Hassan Cheema, Sidra Shafiq Cheema, Afia Sarwar, Haniya Zainab Siddique
Publikováno v:
PLoS ONE, Vol 18, Iss 8 (2023)
Background and objectives Vaccine hesitancy is a big obstacle for vaccination programs, as is anticipated for the COVID-19 vaccination program, resulting in low uptake of vaccines thereby hindering the process of reaching herd immunity. Bearing this
Externí odkaz:
https://doaj.org/article/22e08bd0fab0410fa61c944d11cd4915
Autor:
Shafiq Ur Rehman Cheema, Muhammad Salman Rehman, Ghulam Hussain, Sidra Shafiq Cheema, Nooman Gilani
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background There is paucity of data using direct anti-viral agents (DAA) in patients on maintenance hemodialysis (MHD) infected with HCV-genotype 1 & 3. Aim of the study was to evaluate DAA therapy in patients infected with HCV-genotype 1 &
Externí odkaz:
https://doaj.org/article/c872d1505a7342daa01fa41b9215c359
Publikováno v:
American Journal of Hypertension.
Background In the original SPRINT article, age was categorized at 75 years, which was contrary to many previous clinical trials which is at 60 years. Methods The SPRINT trial randomized 9,361 hypertensive patients to a target blood pressure of Result
Publikováno v:
International Journal of Infection Control.
Hand hygiene (HH) serves as a primary public health measure against healthcare-associated infections. During the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), HH has b
Autor:
Haniya Zainab Siddique, Afia Sarwar, Sidra Shafiq Cheema, Mumtaz Touseef, Naveen Siddique Sheikh, Riddah Sultan, Kanwal Hassan Cheema
Background and objectivesVaccine hesitancy is a big obstacle for vaccination programs, as is anticipated for the COVID-19 vaccination program, resulting in low uptake of vaccines thereby hindering the process of reaching herd immunity. Bearing this i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce2e33f409e14de8d9d40318ac9264bb
https://doi.org/10.1101/2021.07.12.21260409
https://doi.org/10.1101/2021.07.12.21260409
Publikováno v:
Pakistan Journal of Kidney Diseases. 4
Background: Direct acting antiviral therapies (DAA) are an important tool for hepatitis C virus elimination. Cross-contamination as a result of failure to follow infection control procedures. We estimated HCV reinfection rates among treated individua
Autor:
Sidra Shafiq Cheema, Muhammad Salman Rehman, Nooman Gilani, Shafiq Ur Rehman Cheema, Ghulam Hussain
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Background There is paucity of data using direct anti-viral agents (DAA) in patients on maintenance hemodialysis (MHD) infected with HCV-genotype 1 & 3. Aim of the study was to evaluate DAA therapy in patients infected with HCV-genotype 1 & 3 on MHD.